User profiles for Isik S Johansen
 | Isik Somuncu JohansenDepartment of Infectious Diseases, Odense University Hospital Verified email at dadlnet.dk Cited by 1911 |
[PDF][PDF] Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer
…, S Østerlev, H Vestergaard, US Justesen, IS Johansen… - Cancer cell, 2021 - cell.com
Patients with solid and hematologic cancer are more vulnerable to SARS-CoV-2 infection
and have poorer prognoses of COVID-19 because of their general health status, …
and have poorer prognoses of COVID-19 because of their general health status, …
[HTML][HTML] Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.
Background The trans-membrane protease serine 2 (TMPRSS2) is essential for severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry and infection. Efficacy and …
respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry and infection. Efficacy and …
[HTML][HTML] Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial
…, IN Lu, T Benfield, H Nielsen, IS Johansen… - Nature medicine, 2022 - nature.com
Attempts to reduce the human immunodeficiency virus type 1 (HIV-1) reservoir and induce
antiretroviral therapy (ART)-free virologic control have largely been unsuccessful. In this …
antiretroviral therapy (ART)-free virologic control have largely been unsuccessful. In this …
Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors
C Andréjak, VØ Thomsen, IS Johansen… - American journal of …, 2010 - atsjournals.org
Rationale: Few population-based data are available regarding nontuberculous mycobacteria
(NTM) pulmonary disease epidemiology and prognosis. Objectives: To examine NTM …
(NTM) pulmonary disease epidemiology and prognosis. Objectives: To examine NTM …
[HTML][HTML] Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial
…, H Nielsen, IS Johansen, T Benfield, S Leth… - Nature Medicine, 2023 - nature.com
Inducing antiretroviral therapy (ART)-free virological control is a critical step toward a human
immunodeficiency virus type 1 (HIV-1) cure. In this phase 2a, placebo-controlled, double-…
immunodeficiency virus type 1 (HIV-1) cure. In this phase 2a, placebo-controlled, double-…
[HTML][HTML] Tuberculous meningitis in Denmark: a review of 50 cases
…, VØ Thomsen, PH Andersen, IS Johansen - BMC Infectious …, 2011 - Springer
Background Tuberculous meningitis is the most severe manifestation of extrapulmonary
tuberculosis with a high mortality rate and a high rate of sequelae among survivors. The aim of …
tuberculosis with a high mortality rate and a high rate of sequelae among survivors. The aim of …
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial
…, M Helleberg, S Meegada, IS Johansen… - The Lancet, 2022 - thelancet.com
Background Passive immunotherapy using hyperimmune intravenous immunoglobulin (hIVIG)
to SARS-CoV-2, derived from recovered donors, is a potential rapidly available, specific …
to SARS-CoV-2, derived from recovered donors, is a potential rapidly available, specific …
Characteristics and clinical outcome of bone and joint tuberculosis from 1994 to 2011: a retrospective register-based study in Denmark
IS Johansen, SL Nielsen, M Hove… - Clinical Infectious …, 2015 - academic.oup.com
Background. Most information on bone-joint (BJ)-tuberculosis is based on data from high-incidence
areas. We conducted a nationwide register-based analysis of BJ-tuberculosis in …
areas. We conducted a nationwide register-based analysis of BJ-tuberculosis in …
[HTML][HTML] Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis
…, EA Graviss, S Bjerrum, IS Johansen… - The Lancet Infectious …, 2022 - thelancet.com
Background The WHO-recommended tuberculosis screening and diagnostic algorithm in
ambulatory people living with HIV is a four-symptom screen (known as the WHO-…
ambulatory people living with HIV is a four-symptom screen (known as the WHO-…
[HTML][HTML] Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines
…, D Raben, J Reekie, H Nielsen, IS Johansen… - Frontiers in …, 2022 - frontiersin.org
The SARS-CoV-2 pandemic has, as of July 2022, infected more than 550 million people and
caused over 6 million deaths across the world. COVID-19 vaccines were quickly developed …
caused over 6 million deaths across the world. COVID-19 vaccines were quickly developed …